anyone else notice glucagon kicking in around week 51
Check-in as promised in the title: anyone else notice glucagon kicking in around week 51. Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer. Independent purity testing on this compound is thin…
Read the phase 2 paper twice before ordering anything. Recommend that to anyone in this board: the error bars are the interesting part.
Agreed, and the framing that helps is: this is a phase 2 compound with phase 3 running. Everything else is inference.
Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.
not approved anywhere, which is the single most important fact in this board
the TRIUMPH programme is still running, so anything definitive is premature
a lot of the confident posting here is extrapolation
The early fullness profile felt different rather than worse. Hard to describe and impossible to quantify, so take it as an impression.
the energy-expenditure story is mechanistically interesting and clinically unproven
Removed the escalation schedule. There is no published protocol for members to follow and inventing one here is exactly what this board does not do.
the glucagon component is why the metabolic story reads differently
Removed the escalation schedule.
reta_and_regret is right about the escalation being the variable. It explains most of the difficult reports here.